These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1449044)

  • 1. Effects of short-term growth hormone treatment on PTH, calcitriol, thyroid hormones, insulin and glucagon.
    Brixen K; Nielsen HK; Bouillon R; Flyvbjerg A; Mosekilde L
    Acta Endocrinol (Copenh); 1992 Oct; 127(4):331-6. PubMed ID: 1449044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of growth hormone and parathyroid hormone in renal phosphate, calcium, and calcitriol metabolism and bone remodeling in postmenopausal women.
    Lieberman SA; Holloway L; Marcus R; Hoffman AR
    J Bone Miner Res; 1994 Nov; 9(11):1723-8. PubMed ID: 7863823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term treatment with growth hormone stimulates osteoblastic and osteoclastic activity in osteopenic postmenopausal women: a dose response study.
    Brixen K; Kassem M; Nielsen HK; Loft AG; Flyvbjerg A; Mosekilde L
    J Bone Miner Res; 1995 Dec; 10(12):1865-74. PubMed ID: 8619366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study.
    Hansen TB; Brixen K; Vahl N; Jørgensen JO; Christiansen JS; Mosekilde L; Hagen C
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3352-9. PubMed ID: 8784096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone favorably affects bone turnover and bone mineral density in patients with short bowel syndrome undergoing intestinal rehabilitation.
    Tangpricha V; Luo M; Fernández-Estívariz C; Gu LH; Bazargan N; Klapproth JM; Sitaraman SV; Galloway JR; Leader LM; Ziegler TR
    JPEN J Parenter Enteral Nutr; 2006; 30(6):480-6. PubMed ID: 17047171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum calcitriol and parathyroid hormone levels following prolonged infusion of calcitriol in vitamin D replete and depleted rabbits.
    Long JF; Steinmeyer CL; Thornton DJ; Nagode LA
    Res Commun Chem Pathol Pharmacol; 1989 May; 64(2):273-86. PubMed ID: 2740619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraindividual variation in serum thyroid hormones, parathyroid hormone and insulin-like growth factor-1.
    Ankrah-Tetteh T; Wijeratne S; Swaminathan R
    Ann Clin Biochem; 2008 Mar; 45(Pt 2):167-9. PubMed ID: 18325180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of calcitriol and parathyroid hormone on serum aluminum in vitamin D-depleted rabbits fed an aluminum-supplemented diet.
    Long JF; Nagode LA; Steinmeyer CL; Renkes G
    Res Commun Chem Pathol Pharmacol; 1994 Jan; 83(1):3-14. PubMed ID: 8165367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of growth hormone replacement on parathyroid hormone sensitivity and bone mineral metabolism.
    Ahmad AM; Thomas J; Clewes A; Hopkins MT; Guzder R; Ibrahim H; Durham BH; Vora JP; Fraser WD
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2860-8. PubMed ID: 12788900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
    Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
    Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are low plasma levels of 25-(OH)vitamin D a major risk factor for hyperparathyroidism independent of calcitriol in renal transplant patients?
    Lomonte C; Antonelli M; Vernaglione L; Cazzato F; Casucci F; Chimienti D; Bruno A; Cocola S; Verrelli EA; Basile C
    J Nephrol; 2005; 18(1):96-101. PubMed ID: 15772930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid hormone and growth hormone interact to regulate insulin-like growth factor-I messenger ribonucleic acid and circulating levels in the rat.
    Wolf M; Ingbar SH; Moses AC
    Endocrinology; 1989 Dec; 125(6):2905-14. PubMed ID: 2583046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium metabolism, plasma parathyroid hormone, and calcitriol in transient hypertension of pregnancy.
    Lalau JD; Jans I; el Esper N; Bouillon R; Fournier A
    Am J Hypertens; 1993 Jun; 6(6 Pt 1):522-7. PubMed ID: 8343236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitropic hormones and IGF-I are influenced by dietary protein.
    Dubois-Ferrière V; Brennan TC; Dayer R; Rizzoli R; Ammann P
    Endocrinology; 2011 May; 152(5):1839-47. PubMed ID: 21343254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating PTH, Vitamin D and IGF-I levels in relation to bone mineral density in elderly women.
    Lumachi F; Camozzi V; Doretto P; Tozzoli R; Basso SM
    In Vivo; 2013; 27(3):415-8. PubMed ID: 23606700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of insulin-like growth factor I exaggerates the effect of calcium deficiency on bone accretion in mice.
    Kasukawa Y; Baylink DJ; Wergedal JE; Amaar Y; Srivastava AK; Guo R; Mohan S
    Endocrinology; 2003 Nov; 144(11):4682-9. PubMed ID: 12960002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daily or intermittent calcitriol administration during growth hormone therapy in rats with renal failure and advanced secondary hyperparathyroidism.
    Sanchez CP; He YZ
    J Am Soc Nephrol; 2005 Apr; 16(4):929-38. PubMed ID: 15728789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance of nitrogen metabolism to growth hormone treatment in the early phase after injury of patients with multiple injuries.
    Roth E; Valentini L; Semsroth M; Hölzenbein T; Winkler S; Blum WF; Ranke MB; Schemper M; Hammerle A; Karner J
    J Trauma; 1995 Jan; 38(1):136-41. PubMed ID: 7538170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of short-term insulin-like growth factor-I (IGF-I) or growth hormone (GH) treatment on bone metabolism and on production of 1,25-dihydroxycholecalciferol in GH-deficient adults.
    Bianda T; Glatz Y; Bouillon R; Froesch ER; Schmid C
    J Clin Endocrinol Metab; 1998 Jan; 83(1):81-7. PubMed ID: 9435420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.